liklihood for trading halt, page-4

Could be anything but the most likely announcement is regarding the TGA issues - the Chairman hinted at this a couple of weeks ago. It's either the green light to proceed with phase II or serious issues with the pre-clinical data, which means back to the drawing board.

They are low on cash but have the $5mil standby equity facility that they can call on if the get desperate - a SPP or private placement is not their only option.

Anyway, should be interesting to see what they release, here's hoping for the green light to proceed with phase II so the potential of Coramsine can finally be realised..!